Free Trial

Plexus (NASDAQ:PLXS) Receives "Hold (C+)" Rating from Weiss Ratings

Plexus logo with Computer and Technology background

Key Points

  • Plexus (NASDAQ:PLXS) has received a "Hold (C+)" rating from Weiss Ratings, indicating a cautious stance on the stock.
  • The stock has seen varying ratings from analysts, with a consensus average rating of "Moderate Buy" and a consensus price target of $155.60.
  • Plexus reported a quarterly earnings per share (EPS) of $1.90, exceeding estimates by $0.19, supported by a 6% revenue growth year-over-year.
  • Five stocks to consider instead of Plexus.

Plexus (NASDAQ:PLXS - Get Free Report)'s stock had its "hold (c+)" rating reissued by research analysts at Weiss Ratings in a research report issued on Wednesday,Weiss Ratings reports.

Other analysts have also recently issued reports about the stock. Needham & Company LLC lowered their price objective on shares of Plexus from $162.00 to $158.00 and set a "buy" rating for the company in a research note on Thursday, July 24th. Williams Trading set a $165.00 price objective on shares of Plexus in a research note on Monday, September 22nd. Benchmark boosted their price objective on shares of Plexus from $160.00 to $165.00 and gave the company a "buy" rating in a research note on Monday, September 22nd. Sidoti raised shares of Plexus from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $135.00 to $150.00 in a research note on Friday, July 25th. Finally, Stifel Nicolaus set a $140.00 target price on shares of Plexus in a report on Thursday, July 24th. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $155.60.

Read Our Latest Analysis on Plexus

Plexus Stock Up 2.0%

Shares of NASDAQ PLXS opened at $147.28 on Wednesday. Plexus has a 52-week low of $103.43 and a 52-week high of $172.89. The firm has a fifty day moving average of $137.24 and a 200-day moving average of $132.06. The stock has a market capitalization of $3.98 billion, a PE ratio of 25.09 and a beta of 0.80. The company has a quick ratio of 0.74, a current ratio of 1.58 and a debt-to-equity ratio of 0.06.

Plexus (NASDAQ:PLXS - Get Free Report) last announced its quarterly earnings data on Wednesday, July 23rd. The technology company reported $1.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.19. Plexus had a net margin of 4.04% and a return on equity of 12.33%. The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1.02 billion. During the same period in the previous year, the company earned $1.45 EPS. The business's quarterly revenue was up 6.0% compared to the same quarter last year. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. On average, analysts anticipate that Plexus will post 5.9 EPS for the current year.

Insider Buying and Selling

In other Plexus news, insider Victor (Pang Hau) Tan sold 3,000 shares of the business's stock in a transaction on Thursday, August 28th. The shares were sold at an average price of $139.00, for a total value of $417,000.00. Following the transaction, the insider owned 8,723 shares in the company, valued at $1,212,497. The trade was a 25.59% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Todd P. Kelsey sold 1,500 shares of the business's stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $143.70, for a total transaction of $215,550.00. Following the completion of the transaction, the chief executive officer owned 69,214 shares in the company, valued at $9,946,051.80. This represents a 2.12% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,856 shares of company stock valued at $2,142,440 over the last three months. Company insiders own 1.76% of the company's stock.

Hedge Funds Weigh In On Plexus

A number of institutional investors have recently added to or reduced their stakes in PLXS. Fuller & Thaler Asset Management Inc. lifted its holdings in Plexus by 120.4% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 348,510 shares of the technology company's stock worth $44,655,000 after buying an additional 190,360 shares in the last quarter. Nuveen LLC acquired a new position in Plexus in the 1st quarter worth $22,975,000. American Century Companies Inc. lifted its holdings in Plexus by 24.7% in the 1st quarter. American Century Companies Inc. now owns 678,222 shares of the technology company's stock worth $86,901,000 after buying an additional 134,205 shares in the last quarter. Millennium Management LLC raised its stake in shares of Plexus by 85.1% in the 1st quarter. Millennium Management LLC now owns 228,116 shares of the technology company's stock valued at $29,229,000 after purchasing an additional 104,904 shares in the last quarter. Finally, Invesco Ltd. raised its stake in shares of Plexus by 66.1% in the 1st quarter. Invesco Ltd. now owns 211,741 shares of the technology company's stock valued at $27,130,000 after purchasing an additional 84,249 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company's stock.

Plexus Company Profile

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Featured Articles

Analyst Recommendations for Plexus (NASDAQ:PLXS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Plexus Right Now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.